Skip to main content
. 2022 Jun 22;2022(6):CD013285. doi: 10.1002/14651858.CD013285.pub2

Ward 2018.

Methods RCT
Wash‐in period of daily PEP and exercise
Single centre: Adelaide, Australia
Duration: 12 weeks
Participants Inclusion criteria
  • Adults (≥ 18 years of age)

  • Confirmed diagnosis of CF by a positive sweat test (chloride > 60 mmol/L) or identification of two CF‐causing genetic mutations

  • Recruited from the Royal Adelaide Hospital Adult Cystc Fibrosis Service and an active patient (i.e. had attended at least 1 appointment in the last 12 months)

  • Mild respiratory disease (i.e. FEV1 ≥ 70% predicted at baseline assessment) and clinically stable at the time of baseline assessment (i.e. no new medications for ≥ 4 weeks prior to baseline assessment, FEV1 (L) within 10% of most recent value at baseline assessment, no upper respiratory tract infection for ≥ 2 weeks)


Exclusion criteria 
  • Post‐lung transplantation

  • Pregnant

  • Unable to understand written English

  • Pneumothorax in the last 6 months

  • Haemoptysis > 20 mls in the 4 weeks prior to the baseline assessment

  • Positive culture for Burkholderia cepacia within the last 12 months

  • Undergoing treatment for non‐Tuberculosis mycobacteria infection 

  • Had a condition or abnormality that, in the opinion of the treating CF physician, compromised the participant's safety or would otherwise make them unsuitable for participation in the study


Total cohort: 13 participants
Sex: 6 male; 7 female
Disease status: clinically stable, mild disease
Lung function FEV1 % predicted (range): 83% to 115%
Interventions Intervention: daily exercise (with huffing); 30 min of moderate‐ to strong‐intensity exercise (Borg rating of perceived exertion 3 to 5), such as walking or jogging or alternatively 6 cycles of 5 min of step‐ups using an aerobic step, with the height and step rate adjusted to achieve the target exertion intensity. 2 to 3 huffs every 5 minutes
Control: daily PEP (6 cycles of 15 breaths per cycle; 2 to 3 huffs after each cycle) plus exercise (as above)
Outcomes Respiratory function tests; FEV1 (L); FVC (L); FEF25-75
HRQoL: CFQ‐R (respiratory); LCQ
Notes  

CF: cystic fibrosis
CFQ‐R: Cystic Fibrosis Questionnaire ‐Revised
FEF25-75: mid‐peak expiratory flow
FEV1: forced expiratory volume in 1 second
FVC: forced vital capacity
HRQoL: health‐related quality of life
LCQ: Leicester Cough Questionnaire 
PEP: positive expiratory pressure
RCT: randomised controlled trial